In this study, we showed for the first time that human DLBCL cells present an increased expression of CDK5 at both protein and mRNA levels compared to normal lymphocytes, and these data were also confirmed in samples derived from patients with DLBCL as compared to normal B cells. This evidence concerns the gene CDK5 and diffuse large B-cell lymphoma.